Search Videos and More
News
Miami Cancer Institute Physicians Were in the Spotlight at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Physician researchers from the Miami Cancer Institute presented the latest advances and information on new clinical trials from novel therapies to inhibit tumor proliferation and stimulate anti-cancer responses in patients with advanced solid tumors.
Video
The Debrief with Dr. Zinner featuring guest Guenther Koehne, M.D., Ph.D.
Join Dr. Zinner., CEO and Executive Medical Director at Miami Cancer Institute and Dr. Koehne, Deputy Director and Chief of Blood & Marrow Transplant, Hematologic Oncology and Benign Hematology, on the first episode of The Debrief as they discuss some of the latest advancements in hematology.
News
Miami Cancer Institute Takes Action To Address Inequities in Cancer Care with Expanded COTA, Inc. Collaboration
Miami Cancer Institute, part of Baptist Health South Florida, will leverage COTA’s Real-World Analytics to drive standardization of care across all cancer patients
News
Study by Miami Cancer Institute Physician Researchers Promises to Change Way Metastatic Brain Cancer is Treated
For patients with cancer that has metastasized to the brain, the standard treatment for years has been to resect, or surgically remove, the lesion and follow that with radiation therapy (RT) to the whole brain, which prevents relapse by destroying any remaining cancer cells.
News
Baptist Health’s Miami Cancer Institute named as 2022 Recipient of Warren E. Weaver/Richard P. Penna Award
The Board of Pharmacy Specialties (BPS) is pleased to announce the two Warren E. Weaver/Richard P. Penna award winners in the patient care organization and individual category. Baptist Health’s Miami Cancer Institute Pharmacy Program in Miami, FL has been named the 2022 recipient of the Warren E. Weaver/Richard P. Penna Award in the organization category.
News
Beating the Odds: Pancreatic Cancer Survivor is Living Life to the Fullest
At the start of 2019, Bob Dickinson got a diagnosis no one wants - pancreatic cancer. Until very recently, pancreatic cancer cases rarely have had a happy ending, with a traditionally quoted survival rate of just 10 percent. But Mr. Dickinson says he was determined to “make lemonade out of lemons” and was prepared to travel anywhere in the country for the best care.
News
New Therapies Hold Promise for Miami Cancer Institute’s Youngest Patients
According to the American Cancer Society, cancer is now the second leading cause of death, after accidents, in children under the age of 15. But, even though roughly 10,500 U.S. children will be diagnosed with cancer this year, major treatment advances in recent decades have significantly improved pediatric cancer survival rates, experts say.
News
Breast Cancer Treatment Becomes Personal
Today’s breast cancer treatment has evolved into highly personalized care that begins at the molecular level and covers not only medical and surgical strategies, but the patient’s overall sense of wellness.
Video
Miami Cancer Institute's High-Tech High-Touch Approach
Join our experts for a panel discussion on Breast Cancer & Gynecologic Cancer, originally webcast October 21, 2021. Topics included everything from breast cancer prevention, to state-of-the-art holistic treatments, and advances in gynecologic cancer care, including robotics and therapeutics.
News
Miami Cancer Institute Becomes the First and Only APEx Accredited Proton Therapy Facility in the State of Florida
Miami Cancer Institute, part of Baptist Health South Florida, has been granted full accreditation by the ASTRO Accreditation Program for Excellence (APEx ®) for a four-year term effective August 10, 2021.
News
Questions & Answers on Rehabilitation Oncology
Rehabilitation should not be an afterthought in cancer treatment. The sooner strategies are implemented, the better the results, especially when patients have already experienced impairment, says Adrian Cristian, M.D., chief of Cancer Rehabilitation at Miami Cancer Institute.
News
Miami Cancer Institute Study Holds Promise for Patients with Inoperable Pancreatic Cancer
Michael Chuong, M.D., medical director of radiation oncology at the Institute, part of Baptist Health South Florida, presented the long-term results of inoperable pancreas cancer patients who received MR-guided stereotactic ablative radiation therapy (SABR) at the European Society for Radiotherapy and Oncology (ESTRO) 2021 conference in Madrid on August 29, 2021.